Methods | Sample size: not calculated. Intention‐to‐treat: yes. |
|
Participants | Patients with chronic hepatitis D (n =61) from Italy. Inclusion criteria: positive HDV antibody, elevated ALT for one year, histological evidence of chronic hepatitis or cirrhosis, and positive staining for HDAg on liver Bx done within six months . Exclusion criteria were: previous interferon therapy, decompensated cirrhosis, concomitant severe illness, proven drug abuse, prothrombin time greater than 4 s prolonged, platelets < 100,000/cmm, WBC < 3000/cmm, granulocytes < 1500/cmm, creatinine > 1.7 mg/dl, anti‐HIV antibodies. |
|
Interventions | Control: no treatment (n = 30). Experimental 1: interferon alfa‐2b 5 million units (MU) t.i.w. for 4 months, 3 MU thrice a week for 8 months.Duration: 1 year (n = 31). Follow‐up: 1 year post treatment. Liver biopsy at enrolment and second month of post treatment follow‐up. |
|
Outcomes | Normalisation of ALT. Improvement in liver histology. Decrease in HDAg in liver biopsy. Loss of HDV RNA. | |
Notes | Drop outs/withdrawals = 13; 5 from the treatment group and 8 from no treatment. Reasons were ulcer at the injection site in1, acute icteric hepatitis in 1, and non‐compliance 3 in the treatment group and 8 in the control group. Intention‐to‐treat analysis done. However, authors preferred per protocol analysis for the histological improvement. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote "Study patients were randomly assigned to the treatment or control group (no placebo) using a computer‐generated randomisation code." |
Allocation concealment (selection bias) | Unclear risk | Not mentioned. |
Blinding (performance bias and detection bias) All outcomes | High risk | Unblinded trial design. |
Incomplete outcome data (attrition bias) All outcomes | High risk | There were thirteen (out of 61 patients) dropouts during study period. Quote "Of these 61 patients, 48 (79%) have completed 24 months of the study" |
Selective reporting (reporting bias) | Low risk | Outcome measures adequately reported. |